glutathione pharmacokinetics plasma half-life Terminal and the time required to reach steady-state Glutathione! - PMC
Description
Regulatory status CJC-1295 is not FDA-approved for any indication

Availability in different countries Product availability varies across the globe

Once a patient is on a maintenance dose, their B12 levels are generally stable, and a single days difference is unlikely to have a clinical impact

[7] In controlled trials of finasteride for the treatment of male pattern hair loss, 1.4% of patients discontinued therapy due to adverse events, compared with 1.6% of placebo-treated patients

My skins texture improved by a lot it felt smoother and looked more hydrated

revealed that while transient skin-benefitting results were seen in 37.5% of patients with IV glutathione (1200 mg twice weekly for six weeks), 32% developed adverse events, again revealing a large risk-to-benefit ratio imbalance
